G. Weber

发表

Molecular Cloning and Characterization of EndoGlyx-1, an EMILIN-like Multisubunit Glycoprotein of Vascular Endothelium*

F. Eisenhaber, J. Park, H. Ahorn, 2001, The Journal of Biological Chemistry.

A putative human zinc-finger gene (ZFPL1) on 11q13, highly conserved in the mouse and expressed in exocrine pancreas. The European Consortium on MEN 1.

C. Larsson, B. Teh, S. Forbes, 1998, Genomics.

Expression of the RET proto‐oncogene in papillary thyroid carcinoma and its correlation with clinical outcome

C. Larsson, J. Zedenius, G. Wallin, 2001, The British journal of surgery.

Construction of a 1.2-Mb sequence-ready contig of chromosome 11q13 encompassing the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1.

W. V. D. Van de Ven, R. Thakker, G. Carle, 1997, Genomics.

C. Larsson, B. Teh, K. Sandelin, 2022 .

Suppression of the neoplastic phenotype by transfection of phospholipase C β 3 to neuroendocrine tumor cells

C. Larsson, B. Skogseid, K. Öberg, 1999, FEBS letters.

Expression of the VEGF-related factor gene in pre- and postnatal mouse.

C. Larsson, S. Grimmond, F. Piehl, 1996, Biochemical and biophysical research communications.

Mapping of the gene encoding the B56β subunit of protein phosphatase 2A (PPP2R5B) to a 0.5-Mb region of chromosome 11q13 and its exclusion as a candidate gene for multiple endocrine neoplasia type 1 (MEN1)

C. Larsson, S. Forbes, B. Harding, 1997, Human Genetics.

Exclusion of the 13-kDa rapamycin binding protein gene (FKBP2) as a candidate gene for multiple endocrine neoplasia type 1

C. Larsson, N. Hayward, B. Teh, 1995, Human Genetics.

Expression and chromosomal localization of the Requiem gene

C. Larsson, B. Teh, N. Copeland, 1998, Mammalian Genome.

Familial isolated hyperparathyroidism: a distinct genetic entity with an increased risk of parathyroid cancer.

C. Larsson, E. Friedman, M. Nordenskjöld, 1993, The Journal of clinical endocrinology and metabolism.

Genetic mapping of the multiple endocrine neoplasia type 1 locus at 11q13

C. Larsson, N. Hayward, B. Teh, 1995, Journal of internal medicine.

Structure and chromosomal localization of human insulin-like growth factor-binding protein genes.

C. Larsson, H. Luthman, D. Powell, 1993, Growth regulation.

Isolation and mapping of polymorphic cosmid clones used for sublocalization of the multiple endocrine neoplasia type 1 (MEN1) locus

C. Larsson, G. Evans, K. Lewis, 1992, Human Genetics.

Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas.

C. Larsson, M. Bäckdahl, L. Grimelius, 1995, The Journal of clinical endocrinology and metabolism.

Analysis of the cytogenetic stability of the human embryonal kidney cell line 293 by cytogenetic and STR profiling approaches

C. Larsson, W. Lui, G. Weber, 2004, Cytogenetic and Genome Research.

Menin controls the concentration of retinoblastoma protein

G. Weber, P. Gaudray, L. Corset, 2011, Cell cycle.

Gemline Mutations Detected in the von HippeLLindau Disease Tumor Gene by Southern Blot and Direct A Sequencing

Chunde Li, U. Bergerheim, P. Ekman, 1998 .

Cloning and characterization of a novel human gene related to vascular endothelial growth factor.

P. Pollock, N. Hayward, S. Grimmond, 1996, Genome research.

Methylation of the p16INK4A promoter is associated with malignant behavior in abdominal extra-adrenal paragangliomas but not pheochromocytomas.

C. Larsson, M. Bäckdahl, T. Ekström, 2008, Endocrine-related cancer.

Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism.

C. Larsson, N. Hayward, B. Teh, 1998, The Journal of clinical endocrinology and metabolism.

Loss of constitutional heterozygosity in human cancer: A practical approach

C. Larsson, J. Zedenius, G. Weber, 1995 .

Candidate genes for multiple endocrine neoplasia type 1

C. Larsson, N. Hayward, S. Grimmond, 1995, Journal of internal medicine.

Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTC:s.

C. Larsson, M. Nordenskjöld, B. Hamberger, 1994, Human molecular genetics.

Genetic background of MEN1: from genetic homogeneity to functional diversity.

G. Weber, P. Gaudray, 2009, Advances in experimental medicine and biology.

Transcription regulation of the multiple endocrine neoplasia type 1 gene in human and mouse.

M. Fromaget, G. Weber, P. Gaudray, 2003, The Journal of clinical endocrinology and metabolism.

Characterization of the mouse Men1 gene and its expression during development

C. Larsson, N. Hayward, B. Teh, 1998, Oncogene.

Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1.

C. Larsson, N. Hayward, B. Teh, 1997, Human molecular genetics.

Loss of parafibromin expression in a subset of parathyroid adenomas.

C. Larsson, B. Leibiger, I. Leibiger, 2006, Endocrine-related cancer.

A comparative study of the expression patterns for vegf, vegf-b/vrf and vegf-c in the developing and adult mouse.

C. Larsson, F. Piehl, J. Lagercrantz, 1998, Biochimica et biophysica acta.

Genetics of Multiple Endocrine Neoplasia Type 1 a

C. Larsson, B. Teh, G. Weber, 1994, Annals of the New York Academy of Sciences.

Homozygotes for the autosomal dominant neoplasia syndrome (MEN1).

C. Larsson, M. Brandi, R. Castello, 1993, American journal of human genetics.

Sublocalization of the multiple endocrine neoplasia type 1 gene.

C. Larsson, G. Weber, M. Janson, 1992, Henry Ford Hospital medical journal.

Predictive testing for multiple endocrine neoplasia type 1 using DNA polymorphisms.

C. Larsson, Y. Nakamura, N. Hayward, 1992, The Journal of clinical investigation.

Multiple endocrine neoplasia type 1 gene expression is normal in sporadic adrenocortical tumors.

F. Beuschlein, B. Allolio, M. Reincke, 2000, European journal of endocrinology.

The phospholipase C beta 3 gene located in the MEN1 region shows loss of expression in endocrine tumours.

N. Hayward, B. Teh, S. Grimmond, 1994, Human molecular genetics.

Assignment of the human FAU gene to a subregion of chromosome 11q13.

C. Larsson, W. V. D. Van de Ven, E. Schoenmakers, 1993, Genomics.

A rapid method for DNA extraction from fine-needle aspiration biopsies of thyroid tumors, and subsequent RET mutation analysis.

T. Dwight, C. Larsson, M. Bäckdahl, 1998, Cancer detection and prevention.

Exclusion of FAU as the multiple endocrine neoplasia type 1 (MEN1) gene.

C. Larsson, E. Friedman, K. Sandelin, 1993, Human molecular genetics.

Characterization of the MEN1 ortholog in zebrafish.

J. Dumanski, K. P. O'Brien, G. Weber, 1999, Biochemical and biophysical research communications.

Molecular characterization of a recurring complex chromosomal translocation in two human extragonadal germ cell tumors.

A. Tanigami, C. Larsson, Y. Nakamura, 1994, Cancer genetics and cytogenetics.

Report of the Sixth International Workshop on Human Chromosome 11 Mapping 1998

T. Thangarajah, M. Hattori, D. Gerhard, 1999, Cytogenetic and Genome Research.

Targeted disruption of the mouse phospholipase C β3 gene results in early embryonic lethality

C. Larsson, C. Betsholtz, B. Skogseid, 1998, FEBS letters.

Exclusion of the phosphoinositide-specific phospholipase Cβ3 (PLCB3) gene as a candidate for multiple endocrine neoplasia type 1

C. Larsson, N. Hayward, S. Grimmond, 1996, Human Genetics.

Characterization of the chromosomal gene and promoter for human insulin-like growth factor binding protein-5.

C. Larsson, H. Luthman, D. Powell, 1994, The Journal of biological chemistry.

Multiple endocrine neoplasia type 1 and the search for the genetic trigger.

C. Larsson, B. Teh, O. Nilsson, 1997, Hormone research.

Expression of LAZ3/BCL6 in follicular center (FC) B cells of reactive lymph nodes and FC-derived non-Hodgkin lymphomas

F. Piehl, M. Nordenskjöld, J. Lagercrantz, 1997, Leukemia.

Molecular cloning of a novel human gene encoding a 63-kDa protein and its sublocalization within the 11q13 locus.

T. Feng, A. Sancar, I. Dotan, 1997, Genomics.

Linkage disequilibrium studies in multiple endocrine neoplasia type 1 (MEN1)

M. McCarthy, C. Larsson, B. Teh, 1997, Human Genetics.

Heterogeneity at the 5'-end of MEN1 transcripts.

M. Fromaget, G. Weber, P. Gaudray, 2000, Biochemical and biophysical research communications.

Gene identification in autosomal dominant disorders.

C. Larsson, B. Teh, J. Lagercrantz, 1997, AJNR. American journal of neuroradiology.

MUTATIONSOFCODON 918 INTHE RET PROTO-ONCOGENECORRELATE TOPOORPROGNOSISINSPORADIcMEDULLARYTHYROIDCARCINOMAS

C. Larsson, L. Grimelius, J. Zedenius, 1995 .

Characterization of the murine VEGF-related factor gene.

N. Hayward, S. Grimmond, M. Nordenskjöld, 1996, Biochemical and biophysical research communications.

A sequence highly similar to PNG is located on chromosome 22q12 in intron 15 of the LIMK‐2 gene

J. Lagercrantz, G. Weber, Darek Kedra Emma Carson, 1998, Biochemistry and molecular biology international.

Sequence and Expression of the Mouse Homologue to Human Phospholipase C β3 Neighboring Gene

J. Dumanski, F. Piehl, D. Kedra, 1996 .

Isolation and characterization of a novel gene close to the human phosphoinositide-specific phospholipase C beta 3 gene on chromosomal region 11q13.

C. Larsson, M. Nordenskjöld, J. Lagercrantz, 1996, Genomics.

UKCCCR guidelines for the use of cell lines in cancer research

T. Thangarajah, M. Hattori, N. Saitou, 1999, Cytogenetic and Genome Research.

Germline mutations detected in the von Hippel‐Lindau disease tumor suppressor gene by southern blot and direct genomic DNA sequencing

B. Norlén, Chunde Li, U. Bergerheim, 1998, Human mutation.

Expression of the phosphoinositide‐specific phospholipase Cβ3 gene in the rat

C. Larsson, F. Piehl, M. Nordenskjöld, 1995, Neuroreport.

Genomic organization and complete cDNA sequence of the human phosphoinositide-specific phospholipase C beta 3 gene (PLCB3).

C. Larsson, N. Hayward, S. Grimmond, 1995, Genomics.